おかえりなさい
アカウント登録
siteでログインする
siteで登録する
受信トレイを確認する
US WorldMeds
About
US WorldMeds is a closely-held, Kentucky-based specialty pharmaceutical company. Our mission is to develop, license and commercialize
- Louisville,Kentucky,United States
- 51 - 100
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $15M
- Industries
- Health Care,Pharmaceutical
- Founded date
- Mar 23, 2001
- Number Of Employee
- 51 - 100
- Operating Status
- Active
- Legal Name
- USWM LLC.
US WorldMeds is a closely-held, Kentucky-based specialty pharmaceutical company. Our mission is to develop, license and commercialize unique and significant specialty pharmaceuticals that address unmet medical needs or overcome limitations of existing products.Organized on March 23, 2001 by current CEO Paul Breckinridge "Breck" Jones, US WorldMeds holds true to our founder's original vision to become a substantial global operating enterprise while remaining closely-held and able to capitalize on local and experienced talent. US WorldMeds remains committed to continue to expand into a major corporate citizen and a formidable source of innovative pharmaceutical products and high-quality jobs for generations to come - both in our Louisville headquarters and our satellite offices and manufacturing facilities.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 1, 2016 | Series Unknown | — | 1 | — | — | Detail |
| Jun 18, 2013 | Grant | $15M | 1 |
National Institute on Drug Abuse (NIDA)
|
— | Detail |
| Nov 13, 2006 | Seed | — | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institute on Drug Abuse (NIDA)
|
Yes | Grant |
CRG
|
— | Series Unknown |
Keyhorse Capital (KSTC)
|
— | Seed |
Employee Profiles
Acquisition
US WorldMeds has acquired 1 organizations. Their most recent acquisition was Solstice Neurosciences on Aug 13, 2010. They acquired Solstice Neurosciences for $35.70M.
|
Date
Company Name
|
Industry | Acquisition Type | Price | |
|---|---|---|---|---|
|
Aug 13, 2010
Solstice Neurosciences
|
Biotechnology | acquisition | $ 35.70M | Detail |
